Maculogix

Device to measure dark adaptation function to diagnose retinal disease

placeHummelstown, Pennsylvania, United States calendar_todayFounded 2004 groups73 employees language maculogix.com

Registered entities

Investor mix

10 investors on record; lead investors include Vivo Capital, Berwind Private Equity, LSGPA, Roche.

Investor typeCountShare
Venture capital440%
Private equity330%
Bank & private debt110%
Other / undisclosed220%
Coming soon